glp 1 agonist black box warning Medicare's GLP-1 subsidy risks creating lasting expectations What Really Happens When You

doi: 10.1210/en.2011-1070

"Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond"

An adult Gila monster can consume all the energy it needs to survive a full year underground in just three to four meals

10 In particular, semaglutide was most successful at reducing alanine transaminase (mean difference, 14.70 U/L), aspartate transaminase (mean difference, 9.32 U/L), g-glutamyl transferase (mean difference, 16.56 U/L), and liver stif fness measurement (mean difference, 3.08 kPa) compared with the other medications studied, whereas liraglutide demonstrated efficacy in reducing subcutaneous adipose tissue (mean difference, 30.27 cm 2 ) and liver fat fraction (mean difference, 5.16%)

The dual-receptor action appears to create somewhat stronger gut effects

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: A report of the american college of cardiology/american heart association task force on clinical practice guidelines